Week in review: Vitreous biomarkers of dementia, research in ophthalmic AI, deferral of high-dose aflibercept
- Posted on: Jul 7 2023
- Leave a response
High tau levels are found in the vitreous of patients with dementia, a new research center for ophthalmic AI opens in New York, and the FDA declines to approve high-dose aflibercept for diabetic macular edema.
Source: AAO
Posted in: Uncategorized
